SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bionor Pharma ASA Release: Study of Vacc-4x Combined With Celgene's Revlimid® (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin